EA
BIO icon

Emerald Acquisition’s Bio-Rad Laboratories Class A BIO Stock Holding History

Emerald Acquisition’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$52.7M Sell
321,498
-111,332
-26% -$16.9M 0.1% 230
2016
Q2 		$61.9M Buy
+432,830
New +$61.7M 0.11% 209

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Emerald Acquisition's BIO Position: Q3 2016 in Review

Emerald Acquisition reduced its Bio-Rad Laboratories Class A (BIO) stake by 26% in Q3 2016, selling an estimated $16.9M and leaving 321,498 shares worth $52.7M. The position accounts for 0.1% of the portfolio, ranked #230.

Emerald Acquisition first reported a position in BIO in Q2 2016 and has held it in 2 quarters since. The position peaked at $61.9M in Q2 2016. 241 funds tracked by Wall St. Rank hold BIO as of Q3 2016.

  • Emerald Acquisition held 321,498 shares of Bio-Rad Laboratories Class A worth $52.7M as of Q3 2016.
  • Emerald Acquisition sold 111,332 Bio-Rad Laboratories Class A shares in Q3 2016, an estimated $16.9M.
  • Bio-Rad Laboratories Class A made up 0.1% of Emerald Acquisition's portfolio in Q3 2016, its #230 holding.
  • Emerald Acquisition first reported a position in Bio-Rad Laboratories Class A in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Bio-Rad Laboratories Class A position peaked at $61.9M in Q2 2016.
  • 241 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.